CN107110854A - 分析液滴内容物的方法及相关装置 - Google Patents
分析液滴内容物的方法及相关装置 Download PDFInfo
- Publication number
- CN107110854A CN107110854A CN201580063456.5A CN201580063456A CN107110854A CN 107110854 A CN107110854 A CN 107110854A CN 201580063456 A CN201580063456 A CN 201580063456A CN 107110854 A CN107110854 A CN 107110854A
- Authority
- CN
- China
- Prior art keywords
- drop
- aggregation
- entity
- signal
- target composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 130
- 238000004458 analytical method Methods 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 claims abstract description 169
- 230000002776 aggregation Effects 0.000 claims abstract description 122
- 238000004220 aggregation Methods 0.000 claims abstract description 121
- 239000002245 particle Substances 0.000 claims abstract description 91
- 238000005259 measurement Methods 0.000 claims abstract description 65
- 239000007788 liquid Substances 0.000 claims description 41
- 238000001514 detection method Methods 0.000 claims description 33
- 239000000427 antigen Substances 0.000 claims description 31
- 102000036639 antigens Human genes 0.000 claims description 31
- 108091007433 antigens Proteins 0.000 claims description 31
- 230000008569 process Effects 0.000 claims description 24
- 239000012530 fluid Substances 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 21
- 108090000623 proteins and genes Proteins 0.000 claims description 21
- 102000004169 proteins and genes Human genes 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 18
- 238000010494 dissociation reaction Methods 0.000 claims description 12
- 230000005593 dissociations Effects 0.000 claims description 11
- 230000010354 integration Effects 0.000 claims description 11
- 238000009826 distribution Methods 0.000 claims description 7
- 239000012634 fragment Substances 0.000 claims description 6
- 150000002632 lipids Chemical class 0.000 claims description 4
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 4
- 150000002500 ions Chemical class 0.000 claims description 2
- 238000007689 inspection Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 124
- 239000000243 solution Substances 0.000 description 40
- 230000005291 magnetic effect Effects 0.000 description 38
- 239000011324 bead Substances 0.000 description 36
- 239000003153 chemical reaction reagent Substances 0.000 description 34
- 239000000839 emulsion Substances 0.000 description 24
- 239000012224 working solution Substances 0.000 description 22
- 238000002474 experimental method Methods 0.000 description 20
- 230000028327 secretion Effects 0.000 description 20
- 230000027455 binding Effects 0.000 description 18
- 239000006249 magnetic particle Substances 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 210000004408 hybridoma Anatomy 0.000 description 15
- 239000012071 phase Substances 0.000 description 13
- 239000012488 sample solution Substances 0.000 description 13
- 238000005516 engineering process Methods 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- 235000020958 biotin Nutrition 0.000 description 11
- 239000007864 aqueous solution Substances 0.000 description 9
- 238000011534 incubation Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 description 8
- 102000014150 Interferons Human genes 0.000 description 8
- 108010050904 Interferons Proteins 0.000 description 8
- 150000001615 biotins Chemical class 0.000 description 8
- 229940079322 interferon Drugs 0.000 description 8
- 101100244387 Candida albicans (strain SC5314 / ATCC MYA-2876) PMT6 gene Proteins 0.000 description 7
- 101150024216 PMT3 gene Proteins 0.000 description 7
- 108010090804 Streptavidin Proteins 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- 239000007995 HEPES buffer Substances 0.000 description 6
- 101150086142 PMT4 gene Proteins 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000006185 dispersion Substances 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 230000003248 secreting effect Effects 0.000 description 6
- 101710120037 Toxin CcdB Proteins 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 229920001983 poloxamer Polymers 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 210000004698 lymphocyte Anatomy 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 101100398584 Arabidopsis thaliana TT10 gene Proteins 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- 210000001185 bone marrow Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 238000005336 cracking Methods 0.000 description 3
- 238000007306 functionalization reaction Methods 0.000 description 3
- 239000011229 interlayer Substances 0.000 description 3
- 238000012417 linear regression Methods 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- HHBBIOLEJRWIGU-UHFFFAOYSA-N 4-ethoxy-1,1,1,2,2,3,3,4,5,6,6,6-dodecafluoro-5-(trifluoromethyl)hexane Chemical compound CCOC(F)(C(F)(C(F)(F)F)C(F)(F)F)C(F)(F)C(F)(F)C(F)(F)F HHBBIOLEJRWIGU-UHFFFAOYSA-N 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 241000699729 Muridae Species 0.000 description 2
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 108010055044 Tetanus Toxin Proteins 0.000 description 2
- 239000012491 analyte Substances 0.000 description 2
- -1 antibody Proteins 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 239000003429 antifungal agent Substances 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000004720 dielectrophoresis Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 238000012165 high-throughput sequencing Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000003018 immunoassay Methods 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000005415 magnetization Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 210000003463 organelle Anatomy 0.000 description 2
- 229920001993 poloxamer 188 Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000002096 quantum dot Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000010897 surface acoustic wave method Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 229960000814 tetanus toxoid Drugs 0.000 description 2
- 238000000954 titration curve Methods 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 239000012103 Alexa Fluor 488 Substances 0.000 description 1
- 239000012114 Alexa Fluor 647 Substances 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 101710098119 Chaperonin GroEL 2 Proteins 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 229940126062 Compound A Drugs 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000004638 bioanalytical method Methods 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 230000006287 biotinylation Effects 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000005293 ferrimagnetic effect Effects 0.000 description 1
- 230000005307 ferromagnetism Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000003226 mitogen Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000005298 paramagnetic effect Effects 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 1
- 229920001992 poloxamer 407 Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000003753 real-time PCR Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012899 standard injection Substances 0.000 description 1
- 210000001768 subcellular fraction Anatomy 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 229920000428 triblock copolymer Polymers 0.000 description 1
- 210000004885 white matter Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
- B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6846—Common amplification features
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
- B01L2200/0668—Trapping microscopic beads
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0673—Handling of plugs of fluid surrounded by immiscible fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0864—Configuration of multiple channels and/or chambers in a single devices comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N2015/0023—Investigating dispersion of liquids
- G01N2015/003—Investigating dispersion of liquids in liquids, e.g. emulsion
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N2015/0092—Monitoring flocculation or agglomeration
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Clinical Laboratory Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Fluid Mechanics (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
Description
Claims (17)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1459903A FR3027396B1 (fr) | 2014-10-15 | 2014-10-15 | Procede d'analyse du contenu de gouttes et appareil associe |
FR1459903 | 2014-10-15 | ||
PCT/EP2015/073942 WO2016059182A1 (fr) | 2014-10-15 | 2015-10-15 | Procédé d'analyse du contenu de gouttes et appareil associé |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107110854A true CN107110854A (zh) | 2017-08-29 |
CN107110854B CN107110854B (zh) | 2019-07-26 |
Family
ID=52684324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201580063456.5A Active CN107110854B (zh) | 2014-10-15 | 2015-10-15 | 分析液滴内容物的方法及相关装置 |
Country Status (7)
Country | Link |
---|---|
US (1) | US10416168B2 (zh) |
EP (1) | EP3207373B1 (zh) |
JP (2) | JP6775498B2 (zh) |
CN (1) | CN107110854B (zh) |
DK (1) | DK3207373T3 (zh) |
FR (1) | FR3027396B1 (zh) |
WO (1) | WO2016059182A1 (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109647550A (zh) * | 2018-12-20 | 2019-04-19 | 北京交通大学 | 一种用于精准控制液滴融合的磁性液体液滴实验芯片 |
CN111565846A (zh) * | 2018-01-15 | 2020-08-21 | 罗伯特·博世有限公司 | 在微流体装置中提供物质的溶液的方法 |
WO2020191954A1 (zh) * | 2019-03-25 | 2020-10-01 | 浙江大学 | 基于弧形斜指换能器的微颗粒多通道分时分离装置及方法 |
CN111733138A (zh) * | 2020-07-30 | 2020-10-02 | 首都医科大学附属北京友谊医院 | 一种循环肿瘤细胞高通量磁力分选方法 |
CN112165989A (zh) * | 2018-04-18 | 2021-01-01 | 高保真生物技术有限公司 | 单细胞分析的微流控方法 |
CN117953476A (zh) * | 2024-02-02 | 2024-04-30 | 深圳大学 | 一种液滴数字酶联免疫吸附测定方法、装置及相关介质 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2984045C (en) | 2015-04-30 | 2024-01-09 | European Molecular Biology Laboratory | Microfluidic droplet detection and sorting |
FR3050212B1 (fr) * | 2016-04-15 | 2020-09-25 | Chu Montpellier | Procede de detection et/ou de caracterisation de cellules tumorales et appareil associe |
KR102009557B1 (ko) * | 2016-09-21 | 2019-08-09 | 고려대학교 산학협력단 | 미세조류 균주 선별용 마이크로 장치 |
EP3351926A1 (en) * | 2017-01-18 | 2018-07-25 | Hifibio | Method for analyzing and selecting a specific droplet among a plurality of droplets and associated apparatus |
EP3375889B1 (en) | 2017-03-17 | 2019-12-11 | HiFiBiO SAS | Single cell analysis |
US11686664B2 (en) * | 2018-01-29 | 2023-06-27 | Hewlett-Packard Development Company, L.P. | Particle categorization |
EP3543351B1 (en) | 2018-03-19 | 2022-08-10 | Ricoh Company, Ltd. | Nucleic acid sample-contained container, method for producing nucleic acid sample-contained container, and nucleic acid sample |
JP7326778B2 (ja) * | 2018-03-19 | 2023-08-16 | 株式会社リコー | 核酸試料含有容器、核酸試料含有容器の製造方法、核酸試料含有容器の製造装置及び核酸試料含有容器の製造プログラム、並びに、核酸試料 |
CA3061157C (en) * | 2018-09-06 | 2023-11-21 | Nicoya Lifesciences, Inc. | Plasmon resonance (pr) system and instrument, digital microfluidic (dmf) cartridge, and methods of using localized surface plasmon resonance (lspr) for analysis of analytes |
EP3629020B1 (en) | 2018-09-25 | 2021-10-27 | bioMérieux | Microfluidic droplet-based assay process and apparatus |
JP7322857B2 (ja) * | 2020-11-02 | 2023-08-08 | 株式会社三洋物産 | 遊技機 |
JP7322858B2 (ja) * | 2020-11-02 | 2023-08-08 | 株式会社三洋物産 | 遊技機 |
KR102394807B1 (ko) * | 2021-10-20 | 2022-05-06 | 비테스코 테크놀로지스 게엠베하 | 하이사이드 스위치의 고장 진단 장치 및 방법 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1750129A2 (en) * | 2001-02-07 | 2007-02-07 | Massachussets Institute of Technology | Optoelectronic detection system |
CN101939649A (zh) * | 2008-01-07 | 2011-01-05 | 卢米耐克斯公司 | 从复杂样品基质中对细胞进行分离和计数 |
CN102648053A (zh) * | 2009-10-27 | 2012-08-22 | 哈佛学院院长等 | 液滴生成技术 |
WO2013041983A1 (en) * | 2011-09-19 | 2013-03-28 | Centre National De La Recherche Scientifique | Microfluidic system |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7629124B2 (en) * | 2006-06-30 | 2009-12-08 | Canon U.S. Life Sciences, Inc. | Real-time PCR in micro-channels |
EP3536396B1 (en) | 2006-08-07 | 2022-03-30 | The President and Fellows of Harvard College | Fluorocarbon emulsion stabilizing surfactants |
ES2611996T3 (es) * | 2006-11-20 | 2017-05-11 | Nanotemper Technologies Gmbh | Caracterización termo-óptica rápida de partículas |
WO2009011808A1 (en) | 2007-07-13 | 2009-01-22 | President And Fellows Of Harvard College | Droplet-based selection |
WO2010005593A1 (en) * | 2008-07-11 | 2010-01-14 | President And Fellows Of Harvard College | Systems and methods of droplet-based selection |
FR2934050B1 (fr) | 2008-07-15 | 2016-01-29 | Univ Paris Curie | Procede et dispositif de lecture d'une emulsion |
US9604214B2 (en) * | 2013-10-01 | 2017-03-28 | Owl biomedical, Inc. | Cell sorting system using microfabricated components |
-
2014
- 2014-10-15 FR FR1459903A patent/FR3027396B1/fr active Active
-
2015
- 2015-10-15 JP JP2017520426A patent/JP6775498B2/ja active Active
- 2015-10-15 EP EP15785075.1A patent/EP3207373B1/fr active Active
- 2015-10-15 US US15/519,490 patent/US10416168B2/en active Active
- 2015-10-15 DK DK15785075.1T patent/DK3207373T3/da active
- 2015-10-15 WO PCT/EP2015/073942 patent/WO2016059182A1/fr active Application Filing
- 2015-10-15 CN CN201580063456.5A patent/CN107110854B/zh active Active
-
2020
- 2020-07-15 JP JP2020121279A patent/JP2020183966A/ja active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1750129A2 (en) * | 2001-02-07 | 2007-02-07 | Massachussets Institute of Technology | Optoelectronic detection system |
CN101939649A (zh) * | 2008-01-07 | 2011-01-05 | 卢米耐克斯公司 | 从复杂样品基质中对细胞进行分离和计数 |
CN102648053A (zh) * | 2009-10-27 | 2012-08-22 | 哈佛学院院长等 | 液滴生成技术 |
WO2013041983A1 (en) * | 2011-09-19 | 2013-03-28 | Centre National De La Recherche Scientifique | Microfluidic system |
CN103930210A (zh) * | 2011-09-19 | 2014-07-16 | 国家科学研究中心 | 微流体系统 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111565846A (zh) * | 2018-01-15 | 2020-08-21 | 罗伯特·博世有限公司 | 在微流体装置中提供物质的溶液的方法 |
CN111565846B (zh) * | 2018-01-15 | 2021-10-01 | 罗伯特·博世有限公司 | 在微流体装置中提供物质的溶液的方法 |
US11389794B2 (en) | 2018-01-15 | 2022-07-19 | Robert Bosch Gmbh | Method for providing a solution of the substance in a microfluidic device |
CN112165989A (zh) * | 2018-04-18 | 2021-01-01 | 高保真生物技术有限公司 | 单细胞分析的微流控方法 |
US11904317B2 (en) | 2018-04-18 | 2024-02-20 | Hifibio Sas | Microfluidic method for single cell analysis |
CN109647550A (zh) * | 2018-12-20 | 2019-04-19 | 北京交通大学 | 一种用于精准控制液滴融合的磁性液体液滴实验芯片 |
CN109647550B (zh) * | 2018-12-20 | 2020-04-17 | 北京交通大学 | 一种用于精准控制液滴融合的磁性液体液滴实验芯片 |
WO2020191954A1 (zh) * | 2019-03-25 | 2020-10-01 | 浙江大学 | 基于弧形斜指换能器的微颗粒多通道分时分离装置及方法 |
CN111733138A (zh) * | 2020-07-30 | 2020-10-02 | 首都医科大学附属北京友谊医院 | 一种循环肿瘤细胞高通量磁力分选方法 |
CN117953476A (zh) * | 2024-02-02 | 2024-04-30 | 深圳大学 | 一种液滴数字酶联免疫吸附测定方法、装置及相关介质 |
Also Published As
Publication number | Publication date |
---|---|
EP3207373A1 (fr) | 2017-08-23 |
EP3207373B1 (fr) | 2019-02-27 |
FR3027396B1 (fr) | 2016-11-25 |
JP2020183966A (ja) | 2020-11-12 |
US20170307626A1 (en) | 2017-10-26 |
JP6775498B2 (ja) | 2020-10-28 |
DK3207373T3 (da) | 2019-06-03 |
WO2016059182A1 (fr) | 2016-04-21 |
CN107110854B (zh) | 2019-07-26 |
FR3027396A1 (fr) | 2016-04-22 |
US10416168B2 (en) | 2019-09-17 |
JP2017532560A (ja) | 2017-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107110854B (zh) | 分析液滴内容物的方法及相关装置 | |
JP6825065B2 (ja) | 分泌物の多細胞アッセイにおけるマイクロ流体デバイスおよびその使用方法 | |
JP7416749B2 (ja) | 細胞分泌物の分析のための装置及び方法 | |
CN108496080A (zh) | 多功能珠及用于捕获靶细胞的方法 | |
US11525826B2 (en) | Method for detecting and/or characterising tumour cells and associated apparatus | |
CN109142756B (zh) | 一种单分子蛋白的检测方法 | |
CN101939648B (zh) | 生物靶标的免疫磁性捕获和成像 | |
JP2021120679A (ja) | 生物学的サンプルから免疫グロブリンγ(IgG)抗体アイソタイプの濃度を決定するための方法および試薬 | |
US20220347690A1 (en) | Method and system for recovering products from an emulsion | |
Lancaster et al. | Rare cancer cell analyzer for whole blood applications: Microcytometer cell counting and sorting subcircuits | |
CN113791207A (zh) | 高灵敏度的免疫检测方法及其应用 | |
Kumari et al. | Microfluidic platforms for single cell analysis: applications in cellular manipulation and optical biosensing | |
Dimatteo | Democratized Microdroplet Technologies for the Analysis of Single Immune Cell Secretions | |
CN117480260A (zh) | 纳米级反应腔室及其使用方法 | |
AU2023208644A1 (en) | Methods for detecting antibody self-association | |
CN117280210A (zh) | 选择细胞的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1236622 Country of ref document: HK |
|
CB03 | Change of inventor or designer information |
Inventor after: Andrew David Griffith Inventor after: Rafael Clement Lee Ming duno Inventor after: Clement Nizak Inventor after: Philip Christensen, the nage pool Inventor after: Jean Mary Pierre Poderi Inventor after: Elodie - Michel - Christina - Liz Le brilliant Inventor after: Alec Godina Inventor before: Andrew David Griffith Inventor before: Rafael Clement Lee Ming duno Inventor before: Clement Nizak Inventor before: Philip Christensen, the nage pool Inventor before: Jean Mary Pierre Poderi Inventor before: Elodie - Michel - Christina - Liz Le brilliant |
|
CB03 | Change of inventor or designer information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220413 Address after: Paris France Patentee after: ESPCI INNOV Patentee after: National Center for scientific research Address before: Paris France Patentee before: ESPCI INNOV |
|
TR01 | Transfer of patent right |